CN103169745A - Traditional Chinese medicine composition for treating hematuria and application thereof - Google Patents
Traditional Chinese medicine composition for treating hematuria and application thereof Download PDFInfo
- Publication number
- CN103169745A CN103169745A CN2011104408980A CN201110440898A CN103169745A CN 103169745 A CN103169745 A CN 103169745A CN 2011104408980 A CN2011104408980 A CN 2011104408980A CN 201110440898 A CN201110440898 A CN 201110440898A CN 103169745 A CN103169745 A CN 103169745A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- herba
- radix
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine composition and application thereof. Particularly, the composition is prepared from the following raw materials in parts by weight: 1-10 parts of pseudo-ginseng powder, 1-10 parts of cabonized hair and 1-10 parts of amber powder. The composition also comprises one or more of the following raw materials: taraxacum, hedyotis diffusa, Rumex madaio, cogongrass rhizome, common cephalanoplos, stir-fried pollen typhae, eclipta, fructus aurantii, dried orange peel, licorice root, phellodendron bark, honeysuckle flower, lysimachia, herba pyrrosiae, climbing fern spore, false wintergreen, mistletoe, madder root, roasted muscardine silkworm, Indian Buead, rhubarb, Centella asiatica, raw radix astragali and Tripterygii Hypoglauci tablet. The traditional Chinese medicine composition can effectively treat various types of hematuria, and has the advantages of high safety, high effectiveness and no side effect.
Description
Technical field
The present invention relates to the field of Chinese medicines.More specifically, the present invention relates to the Chinese medicine composition for the treatment of hematuria and uses thereof.
Background technology
Normal and other disease of hematuria exists simultaneously, and it both can be called separately a disease, again but a symptom of other disease, the clinical various diseases that is common in.Traditional Chinese medical science disease is common in the diseases such as stranguria, lumbago, blood disorder.Along with the development of Diagnostics of Chinese Medicine, clinical differential diagnosis of diseases more and more becomes trend with the dialectical treatment that combines, and is clearer and more definite to the diagnosis of disease, hematuria is more to be existed as a symptom, but it may be long-standing symptom, especially a microscopic hematuria, treats more thorny.Especially the patient of some chronic nephritiss, latent nephritis, urethral syndrome is all the more so.
The common drug for the treatment of hematuria is the platinum capsule at present.
Platinum capsule composition is: Herba Cirsii, Herba Agrimoniae, Radix Rubiae, Rhizoma Imperatae (cooling blood for hemostasis, clearing away heat and promoting diuresis); Radix Notoginseng (hemostasis by removing blood stasis, reducing swelling and alleviating pain); Flos Lonicerae, Fructus Forsythiae, Radix Scutellariae (heat-clearing and toxic substances removing), the Radix Astragali, Cordyceps, Fructus Rosae Laevigatae, Radix Rehmanniae (QI invigorating nourishing kidney, raising body's immunity).
The main effect of platinum capsule has: QI invigorating righting, blood circulation promoting and blood stasis dispelling, cooling blood for hemostasis.Be mainly used in clinically the hematuria that IgA nephropathy causes.
The subject matter of platinum capsule is:
At first, this medicine is applicable to hematuria deficiency of YIN pyretic toxicity stasis blocking and has the patient that the healthy energy virtual loss is the master concurrently, and is limited to the hematuria patient's curative effect due to other obstruction of collaterals by blood stasis.This is because the platinum capsule is dialectical turbid weakened body resistance as main take the damp and hot stasis of blood, and composition is take clearing away heat and eliminating dampness blood circulation promoting and blood stasis dispelling etc. as main, to because of stasis of blood bleeding patients unhelpful.
Secondly, platinum capsule composition is numerous and diverse, easily has side effects.
In addition, the platinum capsule is capsule formulation, although take conveniently, cost of manufacture is higher, and the composition the inside contains the rare medicinal herbss such as Cordyceps, so compare with other drug, the platinum capsule is expensive, and long-term hematuria patient is difficult to bear economically.In addition, there is some patients were to be difficult to tolerance to capsule preparations.
Therefore, the needs research and development are a kind of can overcome above-mentioned deficiency, the Chinese medicine composition of the treatment hematuria that the scope of application is wider, more economical, curative effect is better.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition that can effectively treat hematuria.This Chinese medicine composition prescription is simple, takes easyly, can effectively treat clinical various hematuria, and safe and effective having no side effect.
In a first aspect of the present invention, a kind of Chinese medicine composition is provided, said composition comprises the raw material that forms by following weight portion proportioning:
Radix Notoginseng powder, the 1-10 weight portion, preferably, the 2-6 weight portion, more preferably, 4 weight portions;
Crinis Carbonisatus, the 1-15 weight portion, preferably, the 1-10 weight portion, more preferably, 4 weight portions; With
Succinum powder, the 1-10 weight portion, preferably, the 2-6 weight portion, more preferably, 4 weight portions.
Preferably, the weight ratio of above-mentioned each raw material in Chinese medicine composition of the present invention is 1: 1: 1.
Above-mentioned Chinese medicine composition can be ground into smalls and directly swallow, every day potion, every natural gift are taken for 3 times, 4 weeks were 1 course for the treatment of.
In another aspect of this invention, a kind of Chinese medicine composition is provided, said composition also comprises the raw material of the group that the freely following raw material of one or more choosings forms: Herba Taraxaci, Herba Hedyotidis Diffusae, Radix Rumicis, Rhizoma Imperatae, HERBA CIRSII, Pollen Tyjphae (parched), Herba Ecliptae, Fructus Aurantii, Pericarpium Citri Reticulatae, Radix Glycyrrhizae, Cortex Phellodendri, Flos Lonicerae, Herba Lysimachiae, Folium Pyrrosiae, Spora Lygodii, Herba Pyrolae, Herba Taxilli, Radix Rubiae, Bombyx Batryticatus(processed), Poria, Radix Et Rhizoma Rhei, Herba sambuci chinensis, Radix Astragali and Herba Begoniae Yunnanensis sheet except comprising the above raw material.
In another aspect of this invention, provide a kind of Chinese medicine composition, said composition comprises the raw material that forms by following weight portion proportioning:
Radix Notoginseng powder, the 3-5 weight portion; Crinis Carbonisatus, the 8-10 weight portion; Succinum powder, the 3-5 weight portion; Herba Taraxaci, the 25-35 weight portion; Herba Hedyotidis Diffusae, the 25-35 weight portion; Radix Rumicis, the 10-20 weight portion; Rhizoma Imperatae, the 25-35 weight portion; HERBA CIRSII, the 25-35 weight portion; Pollen Tyjphae (parched), the 5-10 weight portion; Herba Ecliptae, the 25-35 weight portion; Fructus Aurantii, the 5-15 weight portion; Pericarpium Citri Reticulatae, the 5-15 weight portion; And, Radix Glycyrrhizae, 1-6 weight portion.
In another aspect of this invention, provide a kind of Chinese medicine composition, said composition comprises the raw material that forms by following weight portion proportioning:
Radix Notoginseng powder, the 3-5 weight portion; Crinis Carbonisatus, the 8-10 weight portion; Succinum powder, the 3-5 weight portion; Cortex Phellodendri, the 5-10 weight portion; Flos Lonicerae, the 25-35 weight portion; Herba Hedyotidis Diffusae, the 25-35 weight portion; Radix Glycyrrhizae, the 1-6 weight portion; Herba Lysimachiae, the 25-35 weight portion; Folium Pyrrosiae, the 25-35 weight portion; Spora Lygodii, the 25-35 weight portion; Rhizoma Imperatae, the 25-35 weight portion; HERBA CIRSII, the 25-35 weight portion; Pollen Tyjphae (parched), the 5-15 weight portion; Herba Ecliptae, the 25-35 weight portion; And, Pericarpium Citri Reticulatae, 5-15 weight portion.
In another aspect of this invention, provide a kind of Chinese medicine composition, said composition comprises the raw material that forms by following weight portion proportioning:
Herba Pyrolae, the 25-35 weight portion; Herba Taxilli, the 25-35 weight portion; Herba Ecliptae, the 25-35 weight portion; Cortex Phellodendri, the 5-15 weight portion; Folium Pyrrosiae, the 25-35 weight portion; Rhizoma Imperatae, the 25-35 weight portion; HERBA CIRSII, the 25-35 weight portion; Pollen Typhae carbon, the 5-15 weight portion; Crinis Carbonisatus, the 5-15 weight portion; Radix Rubiae, the 10-20 weight portion; Bombyx Batryticatus(processed), the 10-20 weight portion; Herba Hedyotidis Diffusae, the 25-35 weight portion; Poria, the 10-20 weight portion; Pericarpium Citri Reticulatae, the 5-15 weight portion; Radix Glycyrrhizae, the 1-6 weight portion; Succinum powder, the 3-5 weight portion; And, Radix Notoginseng powder, 3-5 weight portion.Except above-mentioned raw materials, described Chinese medicine composition also can comprise: Radix Et Rhizoma Rhei, 5-15 weight portion; Herba sambuci chinensis, the 25-35 weight portion; Radix Astragali, 25-35 weight portion and Herba Begoniae Yunnanensis sheet, 1-10 part (by sheet).
In one side more of the present invention, provide the purposes of above-mentioned Chinese medicine composition on the medicine of preparation treatment hematuria.Described hematuria is mainly caused by IgA nephropathy.
Compositions of the present invention also can with pharmaceutically acceptable carrier combinations, make conventional dosage form according to the pharmaceutical methods of routine, for example can be made into solid formulation, as powder, capsule, pill, tablet, Orally-disintegrating tablet etc.
The Radix Notoginseng powder sweet and slightly bitter taste of selecting in the present composition, warm in nature, return liver, stomach warp.Its effect is: hemostasis, dissipating blood stasis, detumescence, pain relieving.Cure mainly: haematemesis, hemoptysis, epistaxis, have blood in stool, dysentery, metrorrhagia, lump in the abdomen, puerperal blood faints, retention of lochia, fall and flutter blood stasis.Radix Notoginseng has the title of " refreshing medicine stops blooding ", dissipating blood stasis blood, and hemostasis and do not stay the stasis of blood, to have the stagnant person of the stasis of blood concurrently more suitable to hemorrhage.Radix Notoginseng has stronger anastalsis, to different animals, different way of administration and different preparation, all shows obvious anastalsis.
The Crinis Carbonisatus of selecting in the present composition is bitter, tepor.Energy repercussive, hemostasis, diuresis.Cure mainly the cards such as haematemesis, epistaxis, dysentery, stranguria with blood, woman uterine bleeding and dysuria.Experiment shows, Crinis Carbonisatus has certain anastalsis. and Crinis Carbonisatus decocting liquid or alcohol extract can obviously shorten the bleeding time to rat or mouse peritoneal administration. and Crinis Carbonisatus coarse-grain liquid can accelerate the hemagglutinative function of rat to the rat abdominal cavity administration; And can bring out the rat serum plate that disappears and assemble.There is report to point out, the rat platelet aggregation that the Crinis Carbonisatus coarse-grain is induced ADP has more remarkable potentiation, still can reduce significantly the content of rat plasma cAMP, the hint Crinis Carbonisatus has short endogenous system coagulation function, and its hemostasis principle is relevant with cAMP in plasma content.
The succinum mealiness of selecting in the present composition is sweet, flat.Can calmness, diuresis, invigorate blood circulation.Be used for infantile convulsion, epilepsy, cardiopalmus, insomnia, dysuria, dysurea, hematuria, amenorrhea.Mention in " herbal classic is met former " that " succinum wears down the property of oozing profit, and the blood agglomeration bladder person miscarry.With tool for weighing medicine in ancient China under rhubarb wine, control stagnant blood in married woman's abdomen, blood to the greatest extent stops.Blood agglomeration swelling, enlarged abdomen such as drum, and urinary obstruction person, the Lignum Aquilariae Resinatum generation Qi-breaking drug of must holding concurrently is used it ".
Above-mentioned Chinese medicinal components compatibility share, through sick institute, and effect is as the small wooden raft drum, and is simple and convenient, produces better synergism, can effectively improve hematuria patient's clinical symptoms and sign.
Other side of the present invention due to the disclosure of this paper, is apparent to those skilled in the art.In should be understood that within the scope of the present invention, above-mentioned each technical characterictic of the present invention and can making up mutually between specifically described each technical characterictic in below (eg embodiment), thus consist of new or preferred technical scheme.As space is limited, give unnecessary details no longer one by one at this.
Below in conjunction with specific embodiment, further set forth the present invention.Should be understood that these embodiment only to be used for explanation the present invention and be not used in and limit the scope of the invention.The experimental technique of unreceipted actual conditions in the following example carries out according to the normal condition in affiliated field usually.
The specific embodiment
Example 1, Chinese medicine composition composition formula 1 of the present invention and clinical efficacy thereof
The concrete formula (potion side) of an effective Chinese medicine composition embodiment of the present invention is as follows:
Radix Notoginseng powder, 4g;
Crinis Carbonisatus, 4g; With
Succinum powder, 4g.
Said components is ground into smalls, and potion, divided and swallowed for 3 times every day, for example early, middle and late each 1 time.
Observe the clinical efficacy of the various hematurias of this routine traditional Chinese medicine composition for treating.
Method: 60 routine various hematuria patients all treat with this routine Chinese medicine composition, take by above-mentioned usage, and be 1 month the course for the treatment of, during treatment, patient's symptom and sign carried out O﹠A.
Criterion of therapeutical effect: (1) recovery from illness: the routine urinalysis microscopy is normal, without erythrocyte and occult blood, and clinical symptom disappearance; (2) produce effects: without gross hematuria, in routine urianlysis, erythrocyte is treated front obvious minimizing, and clinical symptoms takes a turn for the better.(3) invalid: as to improve without obvious before and after treatment.
Result: in above-mentioned treatment case, the total effective rate of recovery from illness and produce effects is 90.23%, and the patient has no adverse reaction.
Conclusion: above-mentioned therapeutic outcome shows, can treat clinical various hematuria by the compositions of this routine prescription preparation, and safe and effective having no side effect, but prolonged application.
Other formula treatment IgA nephropathy of example 2, the use present composition, renal calculuss
(1) treatment example 1
Utilize traditional Chinese medicine composition for treating IgA nephropathy of the present invention, renal calculus, specifically treat situation and curative effect is as follows:
Patient's data: congratulate certain, the male, 34 years old, the office worker, on March 19th, 2007 examined.
Main suit: hematuria 5 years.
History of present illness: found gross hematuria before 5 years, 3 days reduce afterwards, but still have erythrocyte in microscopy urine, are IgA nephropathy (mesentery hyperplasia accompanied focal segmental atherosclerotic type) through the kidney puncture diagnosis.Once suffered from nephritis in the time of 13 years old.At present urine is brisk and neat, without edema, receive can, abdominal distention vows that gas is many, receive can, frequent flu at ordinary times, pharyngalgia check middle red blood cell of urine+-++, sometimes albumen a little, urine erythrocyte form abnormity rate 80%, pharyngeal congestion, the thin lingual fur point is red, arteries and veins is than string, blood pressure 120/90mmHg.
Tcm diagnosis: hematuria
Dialectical analysis: due to frequent flu, violate on exopathogen, pharyngeal pain, lower intrusion kidney is hindered channels and hematuria.
Method for the treatment of: Qingre Liqi, removing stasis to stop bleeding
Prescription 1: Herba Taraxaci 30g Herba Hedyotidis Diffusae 30g Radix Rumicis 15g Rhizoma Imperatae 30g
The remaining carbon 10g Herba Ecliptae 30g of HERBA CIRSII 30g Pollen Tyjphae (parched) 10g
Fructus Aurantii 10g Pericarpium Citri Reticulatae 10g Radix Glycyrrhizae 4g Radix Notoginseng powder 4g
Succinum powder 4g
Preparation and instructions of taking: said medicine is except Crinis Carbonisatus, Radix Notoginseng powder and Succinum powder, and all decoctings are 30 minutes, fry in shallow oil juice 400ml, average mark 200ml, sooner or later after meal twice oral.In addition, Radix Notoginseng powder, Crinis Carbonisatus, Succinum powder are ground into smalls, are blended at twice institute and fry in shallow oil in Chinese medicine oral in the lump.
Therapeutic outcome: the 4 all rear patient's improving situations of taking medicine, middle red blood cell of urine only is reduced to 1-3, takes again the rear middle red blood cell of urine disappearance of 2 weeks, and the sense of pharyngalgia abdominal distention alleviates, and breathes hard but feel, and is weak.With Herba Taraxaci in above-mentioned prescription, Herba Hedyotidis Diffusae is removed, and adds Radix Pseudostellariae 15, Ganoderma 30, Rhizoma Polygonati 15, and the patient feels suddenly the left side chronic problem every February; the urine color is red; chemically examine and be the isotypy erythrocyte, sees the one piece of strong echo speckle of 4 * 3mm accompanying sound shadow in the left renal calices of ultrasound diagnosis, is renal calculus; xerostomia; the tongue fur BOHUANG, and rapid and stringy pulse is controlled and intended the clearing away heat and promoting diuresis calculus.
Therefore, separately prescribe as follows:
Prescription 2: Cortex Phellodendri 10g Flos Lonicerae 30g Herba Hedyotidis Diffusae 30g Radix Glycyrrhizae 4g
Herba Lysimachiae 30g Folium Pyrrosiae 30g Spora Lygodii 30g Rhizoma Imperatae 30g
HERBA CIRSII 30g Pollen Tyjphae (parched) 10g Crinis Carbonisatus 10g Herba Ecliptae 30g
Pericarpium Citri Reticulatae 10g Radix Notoginseng powder 4g Succinum powder 4g
Preparation and instructions of taking: with prescription 1.
Therapeutic outcome: after 4 weeks of taking medicine, the patient discharges as one piece, Semen phaseoli radiati sample calculus, and the check middle red blood cell of urine disappears, and the ultrasound diagnosis calculus disappears.After again continuous 3 times the check urine samples all normal, ordinary circumstance is good.
Conclusion: above-mentioned case diagnosis is clear and definite, IgA nephropathy, first determine through the renal biopsy inspection, renal calculus is ultrasound diagnosis, rear discharge calculus confirms, the all visible hematuria of these two kinds of diseases, but microcosmic is different, and the last stage examines and is renal hematuria, and middle red blood cell of urine abnormity rate is 80%, by dialectical with heat clearing away treating blood disorders, removing stasis to stop bleeding and hematuria is eliminated, after-stage left side chronic problem and hematuria occurs suddenly is due to renal calculus moves, and the check middle red blood cell of urine is all isotypy, give the clearing away heat and promoting diuresis calculus, 4 weeks of taking medicine are discharged calculus and the hematuria elimination.The above results as seen, this routine described Chinese medicine composition can effectively be treated the hematuria symptom that IgA nephropathy causes.
(2) treatment example 2
Patient's data: Wu, women, 20 years old.
The first visit date: on August 10th, 2004
The main suit: dark brown urine is nearly 5 years repeatedly.
History of present illness: patient's young women, tell in May, 1999 because of the heating after gross hematuria appears, ordinary circumstance still can, do not give attention, urine color depth repeatedly over 5 years, the time heavy when light, the diseases caused by exogenous pathogenic factor postemphasis once further checked that renal needle biopsy was examined and is IgA nephropathy in 2004, sections sclerosis companion mesentery hypertrophy, the present lower limb two slight edema of ankle and foot, moderate pulse, feverish sensation in the palms and soles sense, receive can, defecation is normal.
Health check-up: pharyngeal congestion, two lungs (-), abdominal touch (-), BP140/100mmhg.
Lab testing: normal renal function, urine RBC:++, urine protein+-++.Body of the tongue: red, tongue: BOHUANG is greasy, arteries and veins: count accurately.
Tcm diagnosis: hematuria.
Western medicine diagnose: IgA nephropathy sections sclerosis companion mesentery hypertrophy.
Dialectical analysis: deficiency of spleen and stomach, damp and hotly accumulate resistance.
The Therapeutic Principle: kidney tonifying is profit clearly.
Prescription: Herba Pyrolae 30g, Herba Taxilli 30g, Herba Ecliptae 30g, Cortex Phellodendri 10g, Folium Pyrrosiae 30g, Rhizoma Imperatae 30g, HERBA CIRSII 30g, Pollen Typhae carbon 10g, Crinis Carbonisatus 10g, Radix Rubiae 15g, Bombyx Batryticatus(processed) 15g, Herba Hedyotidis Diffusae 30g, Poria 15g, Pericarpium Citri Reticulatae 10g, Radix Glycyrrhizae 4g.Be decocted in water for oral dose, every day potion.
The further consultation date: on August 17th, 2004
The recent disease feelings of patient are steady, still have slight pharyngalgia, slightly have the soreness of waist weak, thin fur, thready pulse.Treat same the place ahead, add Succinum powder 4g, Radix Notoginseng powder 4g swallows.
The further consultation date: on JIUYUE 2nd, 2004
Patient's disease feelings are clearly better, middle red blood cell of urine+, albumen+, edema of pair of lower extremities goes down, pale tongue, yellow, greasy and thin fur, thready pulse, BP140/95.Add Altace Ramipril.
Prescription: the place ahead adds Radix et Rhizoma Rhei (processed) 10g, Herba sambuci chinensis 30g, Radix Astragali 30g, 5 of Herba Begoniae Yunnanensis sheets, three times on the one.
The further consultation date: on 09 23rd, 2004
Patient's disease feelings are flat, receive can, stool is normal, edema disappears, body of the tongue is slightly red, thin fur, thready pulse.Treat still dirty with clear the kidney invigorating, dampness removing heat clearing and blood circulation promoting hemostatic treatment.Record routine urinalysis RBC 3-5/HP, urine protein+.
Conclusion: from the above results, this case takes a turn for the better through above-mentioned traditional Chinese medicine composition for treating symptom, and middle red blood cell of urine reduces obviously.
All quote in this application as a reference at all documents that the present invention mentions, just as each piece document is quoted separately as a reference.Should be understood that in addition after having read foregoing of the present invention, those skilled in the art can carry out to the present invention change or the modification of various unsubstantialities, and these equivalent form of values fall within the protection domain that the application's appended claims limits equally.
Claims (10)
1. a Chinese medicine composition, is characterized in that, said composition contains the raw material that forms by following weight portion proportioning:
Radix Notoginseng powder, the 1-10 weight portion;
Crinis Carbonisatus, the 1-15 weight portion; With
Succinum powder, the 1-10 weight portion.
2. Chinese medicine composition as claimed in claim 1, is characterized in that, said composition contains the raw material that forms by following weight portion proportioning:
Radix Notoginseng powder, the 2-6 weight portion;
Crinis Carbonisatus, the 1-10 weight portion; With
Succinum powder, the 2-6 weight portion.
3. Chinese medicine composition as claimed in claim 2, is characterized in that, said composition contains the raw material that forms by following weight portion proportioning:
Radix Notoginseng powder, 4 weight portions;
Crinis Carbonisatus, 4 weight portions; With
Succinum powder, 4 weight portions.
4. Chinese medicine composition as claimed in claim 1, it is characterized in that, also comprise the raw material of the group that the freely following raw material of one or more choosings forms in said composition: Herba Taraxaci, Herba Hedyotidis Diffusae, Radix Rumicis, Rhizoma Imperatae, HERBA CIRSII, Pollen Tyjphae (parched), Herba Ecliptae, Fructus Aurantii, Pericarpium Citri Reticulatae, Radix Glycyrrhizae, Cortex Phellodendri, Flos Lonicerae, Herba Lysimachiae, Folium Pyrrosiae, Spora Lygodii, Herba Pyrolae, Herba Taxilli, Radix Rubiae, Bombyx Batryticatus(processed), Poria, Radix Et Rhizoma Rhei, Herba sambuci chinensis, Radix Astragali and Herba Begoniae Yunnanensis sheet.
5. Chinese medicine composition as claimed in claim 4, is characterized in that, said composition contains the raw material that forms by following weight portion proportioning:
Radix Notoginseng powder, the 3-5 weight portion; Crinis Carbonisatus, the 8-10 weight portion; Succinum powder, the 3-5 weight portion; Herba Taraxaci, the 25-35 weight portion; Herba Hedyotidis Diffusae, the 25-35 weight portion; Radix Rumicis, the 10-20 weight portion; Rhizoma Imperatae, the 25-35 weight portion; HERBA CIRSII, the 25-35 weight portion; Pollen Tyjphae (parched), the 5-10 weight portion; Herba Ecliptae, the 25-35 weight portion; Fructus Aurantii, the 5-15 weight portion; Pericarpium Citri Reticulatae, the 5-15 weight portion; And, Radix Glycyrrhizae, 1-6 weight portion.
6. Chinese medicine composition as claimed in claim 4, is characterized in that, said composition contains the raw material that forms by following weight portion proportioning:
Radix Notoginseng powder, the 3-5 weight portion; Crinis Carbonisatus, the 8-10 weight portion; Succinum powder, the 3-5 weight portion; Cortex Phellodendri, the 5-10 weight portion; Flos Lonicerae, the 25-35 weight portion; Herba Hedyotidis Diffusae, the 25-35 weight portion; Radix Glycyrrhizae, the 1-6 weight portion; Herba Lysimachiae, the 25-35 weight portion; Folium Pyrrosiae, the 25-35 weight portion; Spora Lygodii, the 25-35 weight portion; Rhizoma Imperatae, the 25-35 weight portion; HERBA CIRSII, the 25-35 weight portion; Pollen Tyjphae (parched), the 5-15 weight portion; Herba Ecliptae, the 25-35 weight portion; And, Pericarpium Citri Reticulatae, 5-15 weight portion.
7. Chinese medicine composition as claimed in claim 4, is characterized in that, said composition contains the raw material that forms by following weight portion proportioning:
Herba Pyrolae, the 25-35 weight portion; Herba Taxilli, the 25-35 weight portion; Herba Ecliptae, the 25-35 weight portion; Cortex Phellodendri, the 5-15 weight portion; Folium Pyrrosiae, the 25-35 weight portion; Rhizoma Imperatae, the 25-35 weight portion; HERBA CIRSII, the 25-35 weight portion; Pollen Typhae carbon, the 5-15 weight portion; Crinis Carbonisatus, the 5-15 weight portion; Radix Rubiae, the 10-20 weight portion; Bombyx Batryticatus(processed), the 10-20 weight portion; Herba Hedyotidis Diffusae, the 25-35 weight portion; Poria, the 10-20 weight portion; Pericarpium Citri Reticulatae, the 5-15 weight portion; Radix Glycyrrhizae, the 1-6 weight portion; Succinum powder, the 3-5 weight portion; And, Radix Notoginseng powder, 3-5 weight portion.
8. Chinese medicine composition as claimed in claim 7, is characterized in that, said composition also contains the raw material that forms by following proportioning: Radix Et Rhizoma Rhei, 5-15 weight portion; Herba sambuci chinensis, the 25-35 weight portion; Radix Astragali, the 25-35 weight portion; And, the Herba Begoniae Yunnanensis sheet, 1-10 part is by sheet.
9. the arbitrary described Chinese medicine composition of claim 1-8 is in the purposes for preparing on the medicine for the treatment of hematuria.
10. purposes as claimed in claim 9, is characterized in that, described hematuria is caused by IgA nephropathy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104408980A CN103169745A (en) | 2011-12-23 | 2011-12-23 | Traditional Chinese medicine composition for treating hematuria and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104408980A CN103169745A (en) | 2011-12-23 | 2011-12-23 | Traditional Chinese medicine composition for treating hematuria and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103169745A true CN103169745A (en) | 2013-06-26 |
Family
ID=48630233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011104408980A Pending CN103169745A (en) | 2011-12-23 | 2011-12-23 | Traditional Chinese medicine composition for treating hematuria and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103169745A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103768201A (en) * | 2014-01-09 | 2014-05-07 | 刘金荣 | Traditional Chinese medicine preparation for treating qi stagnation and blood stasis IgA nephropathy |
| CN104258217A (en) * | 2014-10-16 | 2015-01-07 | 禤燕华 | Traditional Chinese medicine composition for treating hematuria |
| CN104645028A (en) * | 2015-01-12 | 2015-05-27 | 兰宇 | Compound kidney-tonifying medicine |
-
2011
- 2011-12-23 CN CN2011104408980A patent/CN103169745A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103768201A (en) * | 2014-01-09 | 2014-05-07 | 刘金荣 | Traditional Chinese medicine preparation for treating qi stagnation and blood stasis IgA nephropathy |
| CN103768201B (en) * | 2014-01-09 | 2015-11-25 | 刘金荣 | A kind of Chinese medicine preparation for the treatment of qi stagnation and blood stasis type IgA nephropathy |
| CN104258217A (en) * | 2014-10-16 | 2015-01-07 | 禤燕华 | Traditional Chinese medicine composition for treating hematuria |
| CN104645028A (en) * | 2015-01-12 | 2015-05-27 | 兰宇 | Compound kidney-tonifying medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101116733B (en) | Medicinal pill for clearing away lung heat and treating pulmonary tuberculosis | |
| CN103007234B (en) | Traditional Chinese medicine preparation for treating dysmenorrheal caused by endometriosis and preparation method of preparation | |
| CN104127531B (en) | Traditional Chinese medicine composition for treating enterogastritis and preparation method thereof | |
| CN101433654B (en) | Chinese medicine preparation for treating women's chronic pelvic inflammatory disease and preparation method thereof | |
| CN102772737B (en) | Traditional Chinese medicine composition for treating liver cirrhosis and fibrosis and preparation method thereof | |
| CN106267120A (en) | A kind of Chinese medicine for treating rhinitis preparation and preparation method thereof | |
| CN103920034A (en) | Traditional Chinese medicine composition for alleviating side effects of chemotherapy of cancer patient and preparation method traditional Chinese medicine composition | |
| CN101537159B (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
| CN105497816A (en) | Traditional Chinese medicine preparation for treating atherosclerosis and preparation method thereof | |
| CN104815318A (en) | Traditional Chinese medicine preparation for treating gout | |
| CN102847074B (en) | Blood stasis removing pill for treating ankylosing spondylitis | |
| CN102389508B (en) | Traditional Chinese medicine for treating infertility | |
| CN103169745A (en) | Traditional Chinese medicine composition for treating hematuria and application thereof | |
| CN104623376B (en) | Be used for the treatment of prosopalgic medicine | |
| CN103330837B (en) | Traditional Chinese medicine composition for curing osteoporosis of menopausal women | |
| CN104436121B (en) | It is a kind of to treat irregular menstruation, small distention and fullness in the abdomen, the medicine to fail to be impregnated for a long time | |
| CN103191399A (en) | Traditional Chinese medicine composition for treating bronchial asthma in acute-outbreak period | |
| CN104840865A (en) | Traditional Chinese medicine preparation for treating gouty arthritis | |
| CN105169279A (en) | Traditional Chinese medicine composition for treating knee joint bone hyperplasia | |
| CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
| CN103386104B (en) | Traditional Chinese medicine composite for curing erysipelas and preparation method thereof | |
| CN101167915B (en) | Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method | |
| CN101961481A (en) | Traditional Chinese medicine for treating liver-gallbladder qi stagnation type cholecystitis and preparation method thereof | |
| CN106267073A (en) | A kind of pharmaceutical composition improving stagnation of QI body constitution and a kind of medicine brick and preparation method thereof | |
| CN105597004A (en) | Traditional Chinese medicine combination for treating cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C05 | Deemed withdrawal (patent law before 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130626 |